BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+27.29%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.31B
AUM Growth
+$931M
(+17%)
Cap. Flow
-$8.53M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
41.19%
Holding
231
New
21
Increased
88
Reduced
44
Closed
16
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$74M |
| 2 |
Charles River Laboratories
CRL
|
$42M |
| 3 |
Abbott
ABT
|
$19.7M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$18.1M |
| 5 |
Arvinas
ARVN
|
$17.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$108M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$84.8M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$84.7M |
| 4 |
Gilead Sciences
GILD
|
$35.3M |
| 5 |
Teladoc Health
TDOC
|
$32.6M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Industrials | 0.45% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.09% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Evolent Health
EVH
$1.1B
| $32.1M | 0.51% |
3,548,613
+523,591
| +17% | +$4.74M |
|
52
Pacific Biosciences
PACB
$372M
| $29.5M | 0.47% |
5,734,309
+3,360,522
| +142% | +$17.3M |
|
53
Teleflex
TFX
$5.7B
| $28.1M | 0.45% |
74,719
+15,605
| +26% | +$5.87M |
|
|
HRC
54
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $26.9M | 0.43% |
237,286
+38,524
| +19% | +$4.37M |
|
55
CareDx
CDNA
$697M
| $25.4M | 0.4% |
1,176,730
+454,075
| +63% | +$9.79M |
|
56
QuidelOrtho
QDEL
$1.89B
| $25.3M | 0.4% |
337,528
+177,512
| +111% | +$13.3M |
|
57
Glaukos
GKOS
$5.17B
| $21.9M | 0.35% |
402,148
| – | – |
|
58
Thermo Fisher Scientific
TMO
$185B
| $21.1M | 0.33% |
64,797
+7,561
| +13% | +$2.46M |
|
59
HUTCHMED
HCM
$2.55B
| $20.5M | 0.33% |
817,817
+29,619
| +4% | +$743K |
|
60
Globus Medical
GMED
$8.14B
| $19.9M | 0.32% |
337,837
+40,171
| +13% | +$2.37M |
|
61
Inspire Medical Systems
INSP
$2.55B
| $19.5M | 0.31% |
263,217
+19,760
| +8% | +$1.47M |
|
62
Wave Life Sciences
WVE
$1.3B
| $19.3M | 0.31% |
2,402,858
+850,000
| +55% | +$6.81M |
|
|
GTHX
63
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $19.1M | 0.3% |
721,925
| – | – |
|
|
MTEM
64
DELISTED
Molecular Templates, Inc.
MTEM
| $18.1M | 0.29% |
+86,379
| New | +$18.1M |
|
65
Molina Healthcare
MOH
$9.26B
| $17.7M | 0.28% |
130,619
+45,380
| +53% | +$6.16M |
|
66
Insulet
PODD
$24.4B
| $17.4M | 0.28% |
101,430
+12,185
| +14% | +$2.09M |
|
67
Bio-Rad Laboratories Class A
BIO
$7.83B
| $17.3M | 0.27% |
46,785
+40,035
| +593% | +$14.8M |
|
68
DexCom
DXCM
$31.7B
| $17.2M | 0.27% |
313,900
-361,648
| -54% | -$19.8M |
|
|
WMGI
69
DELISTED
Wright Medical Group Inc
WMGI
| $17.1M | 0.27% |
560,311
-243,980
| -30% | -$7.44M |
|
70
Omnicell
OMCL
$1.52B
| $16M | 0.25% |
196,339
+24,693
| +14% | +$2.02M |
|
71
CVS Health
CVS
$93.5B
| $15.4M | 0.24% |
207,279
+101,591
| +96% | +$7.55M |
|
|
HMSY
72
DELISTED
HMS Holdings Corp.
HMSY
| $15.3M | 0.24% |
517,377
+105,405
| +26% | +$3.12M |
|
73
Integra LifeSciences
IART
$1.22B
| $15M | 0.24% |
257,772
+44,215
| +21% | +$2.58M |
|
|
ABMD
74
DELISTED
Abiomed Inc
ABMD
| $15M | 0.24% |
87,839
-45,192
| -34% | -$7.71M |
|
|
XENT
75
DELISTED
Intersect ENT, Inc
XENT
| $14.2M | 0.23% |
570,902
+112,314
| +24% | +$2.8M |
|